| Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, ... Blood, The Journal of the American Society of Hematology 117 (18), 4691-4695, 2011 | 1132 | 2011 |
| American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma RA Kyle, GC Yee, MR Somerfield, PJ Flynn, S Halabi, S Jagannath, ... Journal of Clinical Oncology 25 (17), 2464-2472, 2007 | 526 | 2007 |
| The Ottawa convention banning landmines, the role of international non-governmental organizations and the idea of international civil society K Anderson European Journal of International Law 11 (1), 91-120, 2000 | 429 | 2000 |
| A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance Z Tian, P D’Arcy, X Wang, A Ray, YT Tai, Y Hu, RD Carrasco, ... Blood, The Journal of the American Society of Hematology 123 (5), 706-716, 2014 | 336 | 2014 |
| Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond CS Chim, SK Kumar, RZ Orlowski, G Cook, PG Richardson, MA Gertz, ... Leukemia 32 (2), 252-262, 2018 | 321 | 2018 |
| RETRACTED: Nuclear Factor-κB p65 Mediates Tumor Necrosis Factor α-induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein M Akiyama, T Hideshima, T Hayashi, YT Tai, CS Mitsiades, N Mitsiades, ... Cancer research 63 (1), 18-21, 2003 | 283 | 2003 |
| Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study M Dimopoulos, DS Siegel, S Lonial, J Qi, R Hajek, T Facon, L Rosinol, ... The lancet oncology 14 (11), 1129-1140, 2013 | 270 | 2013 |
| Triplet therapy, transplantation, and maintenance until progression in myeloma PG Richardson, SJ Jacobus, EA Weller, H Hassoun, S Lonial, NS Raje, ... New England Journal of Medicine 387 (2), 132-147, 2022 | 258 | 2022 |
| 'Global civil society': a sceptical view K Anderson, D Rieff Global Civil Society, Helmut Anheier, Marlies Glasius, Mary Kaldor, eds …, 2005 | 225 | 2005 |
| Squaring the Circle-Reconciling Sovereignty and Global Governance through Global Government Networks K Anderson Harv. L. Rev. 118, 1255, 2004 | 209 | 2004 |
| Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set A Chari, MK Samur, J Martinez-Lopez, G Cook, N Biran, K Yong, ... Blood, The Journal of the American Society of Hematology 136 (26), 3033-3040, 2020 | 189 | 2020 |
| JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human … T Kiziltepe, T Hideshima, K Ishitsuka, EM Ocio, N Raje, L Catley, CQ Li, ... Blood, The Journal of the American Society of Hematology 110 (2), 709-718, 2007 | 182 | 2007 |
| The rise of international criminal law: Intended and unintended consequences K Anderson European Journal of International Law 20 (2), 331-358, 2009 | 160 | 2009 |
| Cost of outpatient blood transfusion in cancer patients PY Crémieux, B Barrett, K Anderson, MB Slavin Journal of clinical oncology 18 (14), 2755-2761, 2000 | 151 | 2000 |
| Law and ethics for autonomous weapon systems: Why a ban won't work and how the laws of war can K Anderson, MC Waxman Stanford University, The Hoover Institution (Jean Perkins Task Force on …, 2013 | 148 | 2013 |
| Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized … S Mohamed, GR Johnson, P Chen, PB Hicks, LL Davis, J Yoon, ... Jama 318 (2), 132-145, 2017 | 146 | 2017 |
| Benzene and multiple myeloma: appraisal of the scientific evidence DE Bergsagel, O Wong, PL Bergsagel, R Alexanian, K Anderson, RA Kyle, ... Blood, The Journal of the American Society of Hematology 94 (4), 1174-1182, 1999 | 104 | 1999 |
| Humanitarian inviolability in crisis: The meaning of impartiality and neutrality for UN and NGO agencies following the 2003-2004 Afghanistan and Iraq conflicts K Anderson Harv. Hum. Rts. J. 17, 41, 2004 | 100 | 2004 |
| What to do with Bin Laden and Al Qaeda terrorists: a qualified defense of military commissions and United States policy on detainees at Guantanamo Bay Naval base K Anderson Harv. JL & Pub. Pol'y 25, 591, 2001 | 100 | 2001 |
| Law and ethics for robot soldiers K Anderson, MC Waxman Policy Review, 2012 | 89 | 2012 |
Matthew WaxmanProfessor of Law, Columbia Law School在 law.columbia.edu 的电子邮件经过验证
